Lesaka Technologies, Inc. LSAK
4.18
0.03
0.72%
as of 25 Sep
- Market cap
- $356.2M
- P/E
- 118×
Follow LSAK
Growth Flags
show if company had growth for consecutive years,
Insider Buys
alert about insiders buying in the last 12 month
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
0.00 | 0.00 | 0.00 | 140.00 |
P/S ratio |
0.48 | 0.55 | 0.58 | 0.55 | |
P/FCF ratio |
0.00 | 0.00 | 43.99 | 13.51 | |
P/Operating CF |
36.79 | (34.52) | 10.74 | 23.43 | |
P/B ratio |
1.85 | 2.01 | 2.16 | 1.92 | |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Sales |
0.70 | 0.80 | 0.78 | 0.76 | |
EV/EBITDA |
36.00 | 26.99 | 21.13 | 9.02 | |
EV/Operating CF |
121.01 | 249.38 | 18.92 | 10.39 | |
EV/FCF |
(28.70) | (32.95) | 59.98 | 18.64 | |
Quick Ratio |
0.78 | 0.70 | 0.76 | 0.74 | |
Current Ratio |
1.61 | 1.57 | 1.54 | 1.59 | |
Net Debt/EBITDA |
11.10 | 10.66 | 9.97 | 9.05 | |
Debt/Assets |
33.79% | 33.80% | 35.17% | 33.09% | |
Debt/Equity |
1.24 | 1.27 | 1.27 | 1.13 | |
Asset Turnover |
1.12 | 1.01 | 1.06 | 1.07 | |
Operating CF/Net income |
(2.08) | (2.99) | 68.06 | 5.90 | |
Capex/Depreciation |
(0.36) | (0.33) | (0.50) | (0.84) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
23.12% | 20.21% | 21.44% | 20.43% | |
Intangible Assets out of Total Assets |
0.52 | 0.49 | 0.49 | 0.48 | |
Share Based Compensation of Revenue |
1.09% | 1.09% | 0.73% | 0.97% | |
Graham Net Nets |
(0.72) | (0.62) | (0.53) | (0.57) | |
Graham Number |
0.00 | 0.00 | 0.00 | 1.44 | |
Earnings Yield |
(25.78%) | (13.21%) | (6.96%) | 0.71% | |
Free Cash Flow Yield |
(5.06%) | (4.39%) | 2.27% | 7.40% | |
Revenue per Share |
2.17 | 2.26 | 2.31 | 2.37 | |
Operating CF per Share |
0.11 | (0.14) | 0.47 | 0.21 | |
Capex per Share |
(0.06) | (0.06) | (0.07) | (0.11) | |
Free Cash Flow per Share |
0.05 | (0.19) | 0.41 | 0.10 | |
Cash per Share |
0.91 | 0.88 | 1.14 | 1.03 | |
Shareholders Equity per Share |
2.24 | 2.38 | 2.35 | 2.58 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
2.24 | 2.38 | 2.35 | 2.58 | |
Free Cash Flow |
4.26 | (15.39) | 32.30 | 8.08 | |
Working Capital |
91.27 | 103.02 | 95.76 | 99.07 | |
Capital Expenditures |
(4.67) | (4.47) | (5.27) | (8.79) | |
Net Current Asset Value |
(235.05) | (232.10) | (213.81) | (226.21) | |
EV/EBIT |
0.00 | 0.00 | 0.00 | 42.98 | |
Capex to Sales |
0.03 | 0.03 | 0.03 | 0.05 | |
Net Profit Margin |
(2.51%) | 2.04% | 0.30% | 1.52% | |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 31.16 | |
| Other line items | |||||
Average Receivables |
37.31 | 52.22 | 40.81 | 43.15 | |
Average Payables |
15.98 | 18.43 | 17.26 | 21.93 | |
Average Inventory |
19.58 | 26.22 | 18.17 | 21.83 | |
Average Assets |
602.37 | 672.61 | 662.08 | 675.39 | |
Average Common Equity |
180.74 | 193.87 | 189.32 | 185.80 |
Columns are period end dates